Britannia dividend 2026: ₹90.50 payout, record date set

Key trigger: record dividend alongside Q4 numbers

Britannia Industries announced its biggest-ever dividend for shareholders while reporting its March quarter results. The board approved a final dividend of ₹90.50 per share. The company also reported a sharp year-on-year rise in quarterly profit, alongside moderate revenue growth. The dividend announcement and the earnings print together lifted sentiment around the stock in the immediate session.

Dividend details: amount, record date, and payment process

Britannia declared a final dividend of ₹90.50 per share. The company fixed 31 July 2026 as the record date for determining shareholder eligibility. The dividend will be paid after approval at the annual general meeting (AGM). The payout will be credited to eligible shareholders’ bank accounts within the stipulated timeline, after applicable tax deduction.

Britannia Q4 performance: profit, revenue, EBITDA and margin

In the March quarter, Britannia’s net profit rose 21.1% year-on-year to ₹678 crore, compared with ₹560 crore in the same quarter last year. Revenue increased 6.5% to ₹4,719 crore. EBITDA rose 5.9% to ₹853 crore. The EBITDA margin, however, declined marginally to 18.1%, indicating that profitability improved in absolute terms but margin expansion was limited.

Stock reaction: session move and recent returns

Following the Q4 results and dividend announcement, Britannia shares gained 1.77% (₹102.50) to close at ₹5,885.50. Over the last one month, the stock delivered about 5.20% returns. Over the last one year, Britannia delivered 9.17% returns, translating to about ₹494 per share in gains, as cited in the data.

Pharma shares in focus: index at new 52-week high

Pharmaceutical stocks saw broad-based demand, with the Nifty Pharma index hitting a new 52-week high of 24,033.45 during Wednesday’s intra-day trade on the NSE. At 11:43 AM, the index was up 1.92%, while the Nifty 50 was up 0.22%. The pharma index was higher for the fifth straight trading day. Over this five-day period, it surged 3.8%, compared with a 0.37% gain in the benchmark index.

Biggest movers: Ajanta leads, several stocks hit new highs

Ajanta Pharma soared 7%. Biocon, Alkem Laboratories, Piramal Pharma, Aurobindo Pharma and Lupin were up 4% each. Zydus Life Sciences, Laurus Labs, Cipla, Dr Reddy’s Laboratories and JB Chemicals and Pharmaceutical rose in the 2% to 3% range. Lupin, Laurus Labs, Granules India and Sai Life Sciences hit their respective new highs during intra-day trade, as per the market update.

Earnings snapshot: Wockhardt’s Q4 growth highlights

Among companies that announced March 2026 quarter results, Wockhardt reported revenue growth of 30% compared to the previous year. The company’s EBITDA rose 147% year-on-year to ₹196 crore, compared with ₹79 crore in the previous year. The overall biotech operations for the quarter stood at ₹252 crore. This represented growth of 126% versus Q4FY25, according to the figures provided.

Brokerage view on Lupin: US concentration and launches

A note referenced analysts at BNP Paribas India on Lupin’s earnings drivers. It said recent revenue growth in Lupin’s US business is supported by only a few products, which the analysts expect to face more competition in FY27/28. The brokerage also believes a large part of Lupin’s FY26E earnings would be supported by the launch of Tolvaptan. Separately, it expects Lupin’s domestic-market revenue growth to lag IPM growth, citing competitive challenges in new therapy markets where established leaders already exist.

HUL dividend and Maruti move: other headline cues

Hindustan Unilever Ltd (HUL) reported consolidated net profit of ₹2,992 crore for the March quarter. Alongside results, its board recommended a final dividend of ₹22 per share, subject to shareholder approval at the AGM. This was in addition to an interim dividend of ₹19 per share announced in October 2025, taking the total dividend for the year to ₹41 per share, and total payout to ₹9,633 crore. The record date for HUL’s final dividend entitlement was fixed as Tuesday, 23 June 2026. In autos, shares of Maruti Suzuki were trading at ₹12,858 in afternoon trade, down 2.75% following the results announcement.

Key data table

Market impact: what these updates signaled

Britannia’s record dividend and higher quarterly profit offered a clear shareholder-return signal, while also highlighting that margin improvement remained limited, given the 18.1% EBITDA margin. In pharma, the Nifty Pharma index’s rise to a 52-week high, alongside broad gains across large and mid-cap names, showed risk appetite within the sector over five straight sessions. Company-specific earnings updates, such as Wockhardt’s strong EBITDA growth and biotech operations expansion in the quarter, added to the positive tone around results-led moves.

Analysis: why investors tracked dividend and sector momentum

Large final dividends from established consumer companies tend to draw attention because they provide a visible cash-return metric alongside earnings. Britannia’s ₹90.50 per share dividend stands out as the biggest in its history in the provided data, with a defined record date of 31 July 2026. In parallel, HUL’s combined dividend of ₹41 per share for FY26 and a stated record date of 23 June 2026 underlined how large-cap FMCG firms are using dividends as part of shareholder payout. Meanwhile, pharma’s index-level momentum was supported by both price action and reported healthy earnings from companies that announced Q4FY26 results, even as brokerage commentary flagged potential competition risks for select US-led growth stories like Lupin.

Conclusion: key dates and what to watch next

Britannia’s dividend announcement sets up 31 July 2026 as the key record date, with payment post AGM approval and tax deduction. HUL’s final dividend record date is 23 June 2026, with the final dividend pending shareholder approval at the AGM. On the market side, the Nifty Pharma index remains in focus after touching 24,033.45 intra-day, while investors continue to track Q4FY26 earnings updates and company-specific drivers behind sector moves.